These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25622927)

  • 41. Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study.
    Valadares EC; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Sao Paulo Med J; 2023; 141(5):e2022517. PubMed ID: 37042863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
    Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
    Int J Clin Exp Med; 2014; 7(11):4191-8. PubMed ID: 25550930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.
    Han YM; Lee J; Choi JM; Kwak MS; Yang JI; Chung SJ; Yim JY; Chung GE
    PLoS One; 2021; 16(12):e0260994. PubMed ID: 34898613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori-specific IgG in chronic haemodialysis patients: relationship of hypergastrinaemia to positive serology.
    Luzza F; Imeneo M; Maletta M; Mantelli I; Tancre D; Merando G; Biancone L; Pallone F
    Nephrol Dial Transplant; 1996 Jan; 11(1):120-4. PubMed ID: 8649619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.
    Kamada Y; Fujii H; Fujii H; Sawai Y; Doi Y; Uozumi N; Mizutani K; Akita M; Sato M; Kida S; Kinoshita N; Maruyama N; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    Proteomics Clin Appl; 2013 Oct; 7(9-10):648-56. PubMed ID: 23775887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
    Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
    Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori infection and iron deficiency in patients with coronary artery disease.
    Fallah S; Ahmadi R; Moradi N; Fadaei R; Sezavar SH; Seifi M
    Cell Mol Biol (Noisy-le-grand); 2016 Jul; 62(8):8-14. PubMed ID: 27545208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease.
    Sunbul M; Kivrak T; Durmus E; Akin H; Aydin Y; Ergelen R; Yilmaz Y; Agirbasli M
    Cardiovasc Ther; 2015 Oct; 33(5):294-9. PubMed ID: 26202098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acidophil bodies in nonalcoholic steatohepatitis.
    Yeh MM; Belt P; Brunt EM; Kowdley KV; Wilson LA; Ferrell L;
    Hum Pathol; 2016 Jun; 52():28-37. PubMed ID: 26980020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
    Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
    J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Henderson E; Burt AD; Day CP; Anstee QM
    J Hepatol; 2014 May; 60(5):1055-62. PubMed ID: 24445215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.
    Li M; Shen Z; Li YM
    World J Gastroenterol; 2013 Nov; 19(41):7024-31. PubMed ID: 24222944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease.
    Monteiro JM; Monteiro GM; Caroli-Bottino A; Pannain VL
    Anal Cell Pathol (Amst); 2014; 2014():526979. PubMed ID: 25763333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Helicobacter pylori infection and severe hyperemesis gravidarum among immigrant women in Norway: a case-control study.
    Vikanes AV; Støer NC; Gunnes N; Grjibovski AM; Samuelsen SO; Magnus P; Melby KK
    Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):41-6. PubMed ID: 23273662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. H. pylori is related to NAFLD but only in female: A Cross-sectional Study.
    Wang J; Dong F; Su H; Zhu L; Shao S; Wu J; Liu H
    Int J Med Sci; 2021; 18(11):2303-2311. PubMed ID: 33967606
    [No Abstract]   [Full Text] [Related]  

  • 59. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathology of non-alcoholic fatty liver disease.
    Bedossa P
    Liver Int; 2017 Jan; 37 Suppl 1():85-89. PubMed ID: 28052629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.